Published in Medicine and Law Weekly, October 14th, 2005
The patent applications, acquired by Guidant Corp. in June 2003 and licensed back to Bioheart on a co- exclusive basis, cover delivery systems for delivering cells, therapeutic agents, particles, and/or other biologics to human tissues.
Bioheart is focused on repairing damaged heart muscle with its MyoCell product, a myogenic cell composition made up of adult muscle stem cells...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.